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The Flavivirus genus (Flaviviridae family) contains a number of important human pathogens,
including dengue and Zika viruses, which have the potential to cause severe disease. In order
to efficiently establish a productive infection in mammalian cells, flaviviruses have developed
key strategies to counteract host immune defences, including the type I interferon response.
They employ different mechanisms to control interferon signal transduction and effector
pathways, and key research generated over the past couple of decades has uncovered new
insights into their abilities to actively decrease interferon antiviral activity. Given the lack of
antivirals or prophylactic treatments for many flaviviral infections, it is important to fully
understand how these viruses affect cellular processes to influence pathogenesis and disease
outcome. This review will discuss the strategies mosquito‐borne flaviviruses have evolved to
antagonise type I interferon mediated immune responses.
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The Flavivirus genus (Flaviviridae) encompasses a myriad of viruses
transmitted by blood‐feeding arthropod species, several of which
represent emergent or re‐emergent pathogens. Important examples
include Zika (ZIKV), dengue (DENV), yellow fever (YFV), Japanese
encephalitis (JEV), and West Nile (WNV) viruses. Human flavivirus
infections are responsible for significant morbidity and mortality
worldwide, eliciting a spectrum of manifestations: from asymptomatic
infections to mild flu‐like symptoms, or more severe complications
such as encephalitis and haemorrhagic fever. Furthermore, congenital
developmental deficits, and neurological syndromes have been associ-
ated with ZIKV infections, a previously neglected member of the genus
(Cao‐Lormeau et al., 2016; de Oliveira & Da Costa Vasconcelos, 2016;
Fauci & Morens, 2016; Gould & Solomon, 2008; Mackenzie, Gubler, &ion.
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wileyoPetersen, 2004; Oehler et al., 2014; Ventura, Maia, Bravo‐Filho, Gois,
& Belfort, 2016).
Flaviviruses are enveloped viruses and possess an 11 kb single
stranded, positive sense RNA genome, encoding a single open reading
frame flanked by highly structured 5′ and 3′ untranslated regions
(UTRs; Lindenbach, Murray, Thiel, & Rice, 2013). During infection,
the viral polyprotein is processed to yield three structural (C: capsid,
prM: premembrane, E: envelope) and seven nonstructural proteins
(NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5; Figure 1a). In
addition, all flaviviruses investigated have been shown to produce
subgenomic flavivirus RNA (sfRNA), a nongene product generated
from incomplete degradation of genomic RNA by the 5′‐3′
exoribonuclease, XRN1 (Clarke, Roby, Slonchak, & Khromykh, 2015;
Donald et al., 2016; Pijlman et al., 2008; Roby, Pijlman, Wilusz, &
Khromykh, 2014).
Type I interferon (IFN‐I) is crucial in the fight against virus infec-
tions. Upon activation, the host's IFN‐I response establishes an antiviral- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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FIGURE 1 (a) Organisation of the flavivirus
genome. The flavivirus genome is composed
of a single‐stranded, positive‐sense RNA, of
approximately 11 kb. The single open reading
frame contains the three structural proteins
(C: capsid, prM: premembrane, E: envelope)
and seven nonstructural (NS) proteins (NS1,
NS2A, NS2B, NS3, NS4A, NS4B, and
NS5). These are flanked on either side by
highly structured 5′ and 3′ untranslated
regions. The gene products are generated
from the single polyprotein by co‐ and
posttranslational cleavage. This also results in
the production of the 2K peptide between
NS4A and NS4B. (b) Structure of ZIKV
subgenomic flavivirus RNA (sfRNA), as
predicted following structural studies and
RNA folding analysis. Although the structure
of sfRNA varies for different flaviviruses, they
all contain similar motifs. All flavivirus sfRNAs
contain stem loop (SL) and dumbbell (DBL)
structures, which consist of conserved
nucleotides capable of forming pseudoknots
(PK). PK are represented by lines. Two sfRNAs
of differing size are produced during ZIKV
infection due to the stalling of XRN1 at the SL
structures. Predicted sfRNAs: stalling at SL1
produces xrRNA1 (red box), and xrRNA2
(blue box) is produced by stalling at SL2
(Akiyama et al., 2016; Donald et al., 2016)
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mount a successful innate immune response, eukaryotic organisms
must first be able to detect the invading pathogen. This is achieved
through the use of a variety of receptors, known as pathogen recogni-
tion receptors (PRRs), which are located on both the cell surface and
within the cytoplasm. These receptors detect peptides or nucleotides
derived from the pathogen, which are known as pathogen associated
molecular patterns (PAMPs). There are several families of PRRs, but
the most important for flavivirus infections are Toll‐like receptors
(TLRs) and RIG‐I like receptors (RLRs) (Munoz‐Jordan & Fredericksen,
2010; Suthar, Aguirre, & Fernandez‐Sesma, 2013). TLRs are membrane
bound and, in humans, the TLR family contains 10 members, each of
which detects specific PAMPs. Of importance during flavivirus infec-
tions are TLR7 and TLR8, which identify single‐stranded RNA (ssRNA),
as well as TLR3, which detects double stranded RNA (dsRNA) produced
during viral replication. As most viruses produce dsRNA during replica-
tion, TLR3 is triggered during the majority of infections. With the
exception of TLR3, all TLRs signal through an intermediate protein,
MyD88, which eventually leads to activation of the NF‐ĸb, MAPK,
ERK, and JNK pathways. Conversely, TLR3 signals through a MyD88
independent pathway, which results in the recruitment of TRIF. This
then signals through the TRAF3 and RIP1 signalling pathways to acti-
vate the transcription factors IFN‐regulatory factor (IRF)‐3, NF‐ĸB,
and AP‐1 to stimulate the IFN‐I pathway (Uematsu & Akira, 2007).
Also involved in the detection of cytoplasmic dsRNA are the
RLRs: RIG‐I and Melanoma Differentiation‐Associated protein 5
(MDA5) (Kato et al., 2006). RIG‐I binds to the 5′‐phosphorylatedends of dsRNA molecules, whereas MDA5 binds internally. Both
contain a DExD/Hbox helicase domain and a C‐terminal domain,
which are involved in the binding of viral dsRNA. In addition, they
possess tandem N‐terminal caspase recruitment domains (CARDs),
which interact with mitochondrial antiviral‐signalling protein
(MAVS), the intermediate signalling molecule located on the outer
membrane of mitochondria. This then signals through IRF3/7 to
activate the transcription of I IFNs (Gack, 2014; Reikine, Nguyen, &
Modis, 2014).
I IFNs bind to the IFN‐α receptor (IFNAR), a heterodimeric
transmembrane receptor consisting of two subunits, IFNAR1 and
IFNAR2. This results in the recruitment and activation of tyrosine
kinases, Janus kinase (JAK1), and tyrosine kinase 2 (Tyk2), through
auto‐ and trans‐ phosphorylation. These recruit and phosphorylate
the cytoplasmic transcription factors, signal transducer and activation
of transcription (STAT) 1 and 2. STAT2 is activated by Tyk2, which is
proceeded by the recruitment and phosphorylation of STAT1 by
JAK1. The activated STAT1/2 proteins heterodimerise, translocate
to the nucleus and associate with IRF‐9 to form the interferon‐
stimulated gene factor 3 (ISGF3) complex. ISGF3 binds to the IFN‐
stimulated response element (ISRE), which directly induces an
antiviral state through the production of several hundred IFN
stimulation genes (ISGs) (Ivashkiv & Donlin, 2014; Schneider, Chevillotte,
& Rice, 2014; Schoggins et al., 2011).
Recent findings have also suggested that in addition to
RIG‐I/MAVS and IFN‐I signalling pathways, the cGAS‐STING pathway
is involved in restricting flavivirus infections (Gack & Diamond, 2016;
TABLE 1 Summary of type 1 interferon inhibitory activities of
flaviviral nonstructural proteins and sfRNA.
Interferon
antagonist Virus Activity
NS2A DENV Inhibition of the JAK/STAT signalling
pathway by decreasing STAT1
phosphorylation
KUNV Suppression of IFN‐β transcription
NS4B DENV Completely blocks interferon signalling




Inhibition of the JAK/STAT signalling
pathway by decreasing STAT1
phosphorylation
YFV Interacts with STING to block RIG‐I
stimulation
NS2B‐NS3 DENV Cleaves MITA or STING
Inhibits IFN production by interacting
directly with IκB kinase ε, disrupting
RIG‐I signalling, blocking serine 386
phosphorylation, and inhibiting IRF3
nuclear translocation
NS5 DENV Targets STAT2 for ubiquitin mediated
proteasomal degradation involving
interactions with UBR4
ZIKV Induces ubiquitin mediated proteasomal
degradation of STAT2
YFV Binds and inhibits STAT2 following
IFN‐I induced phosphorylation of
STAT1, requires
K6 ubiquitination
WNV Inhibits STAT1 phosphorylation
JEV Blocks Tyk2 phosphorylation
sfRNA DENV‐2 Sequesters G3BP1, G3BP2, and CAPRIN1,
Binds and inhibits TRIM25
ZIKV Inhibits IFN‐I response downstream of
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viruses, it exhibits activity against particular positive sense RNA viruses
which do not involve DNA intermediates as part of their life cycle.
Studies involving WNV have illustrated that cGAS (cyclic GMP‐AMP
synthase) knockout mice were more susceptible to infection and
suggested that in the absence of cGAS, base levels of certain antiviral
ISGs are reduced, causing the cell to be more permissive to infection
(Schoggins et al., 2011; Schoggins et al., 2014). Similarly, silencing of
stimulator of IFN genes (STING) resulted in enhanced DENV replication
due to a decrease in the induction of proinflammatory cytokines (Aguirre
et al., 2012; Yu et al., 2012). The importance of the role of the cGAS‐
STING pathway in RNA virus restriction is illustrated by the inhibitory
function of different viral proteins to prevent pathway activation as both
DENV and YFV inhibit the activity of STING through interactions with
NS2B‐NS3 and NS4B, respectively (Aguirre et al., 2012; Ishikawa, Ma,
& Barber, 2009; Yu et al., 2012).
To facilitate propagation, viruses have evolved mechanisms to
subvert host responses such as those mediated by IFN‐I (Randall &
Goodbourn, 2008; Versteeg & Garcia‐Sastre, 2010). Similarly,
flaviviruses have developed several strategies involving one or more
of their nonstructural proteins, in addition to sfRNA, as specific
IFN‐I antagonists to surmount these host immune responses;
although, the viral effectors and mechanisms may differ between
viruses (Table 1). It is important to recognise the factors, which
underlie these immune evasion strategies in order to understand
how they impact disease pathogenesis and for focused vaccine
development. Herein, we review select flavivirus encoded products
and their IFN‐I antagonist capabilities.
RIG‐I & MDA5
WNV Inhibits IFN‐I response through unknown
mechanism
JEV Inhibits IRF‐3 phosphorylation and nuclear
localisation
Note. DENV = dengue virus; IFN = interferon; IFN‐I = type I interferon;
IRF = IFN‐regulatory factor; JAK = Janus kinase; JEV = Japanese encepha-
litis virus; KUNV = Kunjin virus; NS = nonstructural; sfRNA = subgenomic
flavivirus RNA; STAT = signal transducer and activation of transcription;
STING = stimulator of the IFN genes; TRIM = tripartite motif‐containing
protein; Tyk2 = tyrosine kinase 2; UBR4 = ; Ubiquitin protein ligase E3
component N‐Recognin 4; WNV = West Nile virus; YFV = yellow fever
virus; ZIKV = Zika virus.1.1 | NS2A
The flavivirus NS2A protein is small (20 kD), hydrophobic, and associ-
ated with the endoplasmic reticulum. It is a multifunctional protein
with roles in virion assembly (Kummerer & Rice, 2002; Leung et al.,
2008), RNA replication (Mackenzie, Khromykh, Jones, & Westaway,
1998; Rossi, Fayzulin, Dewsbury, Bourne, & Mason, 2007), membrane
permeabilisation (Chang et al., 1999), and dissemination from infected
mosquito midguts (Mcelroy, Tsetsarkin, Vanlandingham, & Higgs,
2006). It has also been shown to act as an interferon antagonist, which
has been described for WNV (Liu et al., 2006), Kunjin virus (KUNV, a
WNV variant) (Liu, Chen, Wang, Huang, & Khromykh, 2004; Liu
et al., 2005), and DENV‐2 (Munoz‐Jordan, Sanchez‐Burgos, Laurent‐
Rolle, & Garcia‐Sastre, 2003). During DENV infection, it is known to
reduce IFN‐α/β signalling through inhibition of the JAK/STAT signal-
ling pathway to impede the induction of ISGs. Individual expression
of NS2A, as well as NS4B and NS4A, facilitated the replication of an
IFN‐sensitive virus, GFP‐tagged Newcastle disease virus (NDV‐GFP),
with NS4B being the most potent. The combined action of DENV‐2
NS2A along with NS4A and NS4B was sufficient to block IFN signalling
completely through a reduction in STAT1 phosphorylation, prohibiting
its nuclear localisation and preventing IFN‐β promoter driven tran-
scription from two ISREs (Munoz‐Jordan et al., 2003). Research on
KUNV has shown that a single amino acid substitution (A30P) is
responsible for the suppression of IFN‐β transcription both in vitro
and in vivo, and results in diminished virulence in mice (Liu et al.,2004; Liu et al., 2006; Melian et al., 2013). Infection by viruses contain-
ing this mutation are highly attenuated, and the production of IFN‐I is
swift and continuous, allowing them to establish a productive infection
in IFN competent cell lines; however, the exact mechanism and cellular
target of its control are unknown (Liu et al., 2006).1.2 | NS2B‐NS3
The NS2B protein interacts with NS3 to form a stable complex which
functions as a serine protease (Falgout, Pethel, Zhang, & Lai, 1991).
Studies have illustrated that the NS2B‐NS3 protease of DENV
interferes with IFN‐I induction via cleavage of MITA/STING (Aguirre
et al., 2012; Yu et al., 2012). Furthermore, through the direct
interaction and modulation of IκB kinase ε, an important kinase
involved in IFN‐I induction, DENV NS2B‐NS3 disrupts RIG‐I signaling,
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thereby decreasing IFN production (Anglero‐Rodriguez, Pantoja, &
Sariol, 2014).1.3 | NS4B
NS4B is known to be an important IFN‐I signalling antagonist during
DENV‐2 infections by inhibiting the JAK/STAT pathway. It functions
by antagonising STAT1 phosphorylation and inhibiting its nuclear
localisation thus preventing ISG induction. This activity has been doc-
umented for both YFV andWNV showing conservation between these
mosquito‐borne viruses (Munoz‐Jordan et al., 2003; Munoz‐Jordan
et al., 2005). The N‐terminal 2K signal peptide sequence of NS4B
(Figure 1a) has also been indicated as critical to IFN inhibition;
although, it can be substituted for another signal peptide with no
impact on NS4B function (Munoz‐Jordan et al., 2003). The activity of
NS4B depends upon its insertion into the ER membrane following
NS4A/NS4B cleavage by the NS2B‐NS3 serine protease. Although
its specific mechanism has not yet been established, the initial 125
amino acids alone are required for IFN‐I inhibition. In particular, amino
acids 77–103 are suggested to interact with cytoplasmic components
involved in IFN stimulation and may be important for antagonistic
activity (Munoz‐Jordan, 2010; Munoz‐Jordan et al., 2003). Alterna-
tively, in WNV NS4B residues E22 and K24 have been shown to be
key to IFN suppression (Munoz‐Jordan et al., 2003). Unlike DENV,
YFV NS4B blocks RIG‐I through an interaction with STING (Ishikawa
et al., 2009). This highlights strain‐specific variations used for IFN
suppression between different flaviviruses.1.4 | NS5
NS5 is the largest, most conserved protein amongst flaviviruses. It con-
fers two enzymatic activities via the N‐terminal methyltransferase
domain, implicated in producing the viral RNA 5′ cap with N7 and 2′‐
O methylation, and the C‐terminal RNA dependant RNA polymerase
(RdRp), which replicates viral RNA (Chang et al., 2016; Davidson,
2009). The methyltransferase activity of NS5 offers some protection
for the virus by producing capped viral RNA, enabling host RNA
mimicry. Methylation at the N7 and 2′‐O sites disguises viral RNA from
cytoplasmic PRRs that recognise single‐stranded RNA possessing a
terminal 5′ triphosphate—a signature of “foreign” RNA—and prevents
identification by IFN‐induced protein with tetratricopeptide repeats 1
(IFIT1) (Chang et al., 2016; Daffis et al., 2010; Decroly, Ferron, Lescar,
& Canard, 2011; Jensen & Thomsen, 2012; Kimura et al., 2013; Szretter
et al., 2012). In addition to these enzymatic functions, NS5 has been
described as a potent flavivirus IFN‐I antagonist (Best, 2017). Despite
its highly conserved nature, the mechanisms by which it dampens the
IFN‐I response vary substantially; although, STAT inhibition has been
described as common mode of action for some flaviviruses.
NS5 inhibition of STAT1/2 activation or translocation prevents the
upregulation of ISGs and the establishment of an antiviral state. DENV
NS5 binds and degrades STAT2 by targeting it for Ubiquitin‐mediated
proteasomal degradation (Ashour, Laurent‐Rolle, Shi, & Garcia‐Sastre,
2009; Mazzon, Jones, Davidson, Chain, & Jacobs, 2009). Ectopic
expression of NS5 alone was not sufficient to induce STAT2degradation. It has been shown that NS5 maturation via N‐terminal
cleavage is required for STAT2 depletion, although the role that this
plays is unclear (Ashour et al., 2009). Degradation is not dependent
on the terminal amino acid residue as both plasmid expressed NS5 with
a terminal methionine, as well as NS5 produced during a native
infection with a terminal glycine are functional (Ashour et al., 2009).
Ubiquitin protein ligase E3 component N‐Recognin 4 (UBR4) has been
identified as binding to DENV NS5 and promoting STAT2 degradation.
DENVNS5 acts as a bridge betweenUBR4 and STAT2, but this appears
to be specific to DENV and is not seen with YFV or WNV (Morrison
et al., 2013). The first 10 amino acids of DENV NS5 are required for
UBR4 binding, and threonine and glycine at positions 2 and 3 respec-
tively were identified as critical for UBR4 binding and STAT2 degrada-
tion (Ashour et al., 2009; Morrison et al., 2013). These residues are
conserved in all DENV serotypes but not in other flaviviruses (Morrison
et al., 2013). Furthermore, it was found that the NS5‐UBR4 interaction
is independent of STAT2. UBR4 lacks an ubiquitin ligase catalytic
domain, and therefore it has been suggested to act as a scaffold for
ubiquitination to target STAT2 for proteasomal degradation (Morrison
et al., 2013). More recently, ZIKV has also been shown to bind and
deplete STAT2 via proteasomal degradation. However, unlike DENV,
this is independent of the production of an authentic NS5 N‐terminus
and UBR4 interaction (Grant et al., 2016). The interaction between
NS5 and STAT2 as well as the suppression of described as a host
species specific affect for both ZIKV and DENV. NS5‐STAT2 binding
is abolished in mouse model systems possessing intact IFN signalling
pathways, and this significantly impedes virus infection (Ashour et al.,
2010; Grant et al., 2016). The converse is observed in mice lacking an
intact IFN system where infections are lethal. Therefore, virus–host
interactions at the level of IFN‐I antagonism have significant
implications in the development of suitable infectious model systems.
Similar to DENV, the extreme N‐terminus of YFV also contains a
motif required for NS5‐STAT2 interactions and subsequent inhibition
(Laurent‐Rolle et al., 2014). Curiously, the YFV NS5‐STAT2 interaction
and resulting IFN‐I antagonism is dependent on stimulation with IFN‐I;
a mechanism thus far unique to YFV in the flavivirus genus (Laurent‐
Rolle et al., 2014). YFV NS5 does not target STAT2 for proteasomal
degradation unlike DENV. Instead, IFN‐I induced phosphorylation of
STAT1, in addition to K63‐linked polyubiqutination via E3 ligase
Tripartite motif‐containing protein 23 (TRIM23) at K6 of NS5, is
required to bind STAT2 and prevents ISGF3 interaction with the IRSE
promoter (Laurent‐Rolle et al., 2014).
The NS5 of virulent WNV strain NY99 has been shown to be a
potent inhibitor of IFN through the inhibition of STAT1 phosphoryla-
tion (Laurent‐Rolle et al., 2010). Transient expression of WNV NY99
NS5 alone was sufficient to rescue NDV‐GFP replication in IFN treated
cells, whereas expression of KUNV NS5 did not (Laurent‐Rolle et al.,
2010). This study was performed in tandem with both virulent and
attenuated forms of JEV NS5 protein and suggested the IFN antago-
nist activity of NS5 appeared to be associated with strain virulence
(Laurent‐Rolle et al., 2010). Mutagenesis studies of WNV NY99
demonstrated a single amino acid mutation (F653S) dampens the
capability of NS5 to suppress IFN‐β mediated STAT1 phosphorylation
and ISRE‐dependent gene expression, whereas the inverse mutation,
S653F, in KUNV augments IFN suppression by NS5 (Laurent‐Rolle
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W651, which are also shown to be important in IFN‐I suppression, lies
within a structural pocket identified in Langat virus to map to the indis-
pensable RdRp domain (Park, Morris, Hallett, Bloom, & Best, 2007).
The action of JEV NS5 presents an alternative mechanism of IFN‐I
signalling inhibition through a Tyk2 phosphorylation blockade. This
induces the cytoplasmic retention of STAT1/2 and prevents IRSE
driven transcription (Lin, Chang, Yu, Liao, & Lin, 2006). No direct
physical association between JEV NS5 and IFN‐I signalling molecules
Tyk2, STAT1, or JAK1 has been demonstrated. Instead the use of
protein tyrosine phosphatases ablates NS5 mediated inhibition of
IFN‐I signalling, suggesting that JEV NS5 may act through cellular
tyrosine phosphatases to exert antagonistic affects (Castillo Ramirez
& Urcuqui‐Inchima, 2015; Lin et al., 2006).1.5 | Flavivirus subgenomic RNA (sfRNA)
Whilst it has been known for over a decade that flavivirus nonstruc-
tural proteins play important roles in the evasion and antagonism of
the host immune response, the antagonistic properties of sfRNA has
more recently came to light. sfRNA is produced during the course of
flavivirus infection of vertebrate cells as a result of incomplete diges-
tion of the 3'UTR by the cellular exonuclease, XRN1 (Clarke et al.,
2015; Pijlman et al., 2008; Roby et al., 2014). The production of these
small RNAs, which are typically around 500 nt, has been shown to be
specific to flaviviruses (Akiyama et al., 2016; Donald et al., 2016; Lin,
Chang, & Chang, 2004; Liu, Chen, & Khromykh, 2003; Moon et al.,
2015; Pijlman et al., 2008; Schnettler et al., 2012; Schnettler et al.,
2014; Schuessler et al., 2012).
Work from the Khromykh laboratory, demonstrated the structure
and mechanism through which sfRNA is generated (Pijlman et al.,
2008). RNA correlating to the relative size of the 3′ UTR was detected
in both vertebrate and invertebrate cells infected with various
flaviviruses or derivative replicons. Due to the absence of an internal
promoter and the apparent reliance on host cell machinery, it was
hypothesised that a cellular exoribonuclease may be responsible for
its production (Pijlman et al., 2008). This was later shown to be due
to stalling by XRN1 (Chapman, Moon, Wilusz, & Kieft, 2014).
The construction of mutant viruses incapable of producing sfRNA
demonstrated that the generation of intact sfRNA was necessary for
effective viral growth and pathogenicity in cell culture and mice
(Pijlman et al., 2008). Whilst the mechanism for this was unclear,
sfRNA was proposed to play a modulatory role in the host antiviral
response. Indeed, IFN‐β promoter activity was reduced in cells
infected with JEV or transfected with JEV‐derived sfRNA (Chang
et al., 2013). In these cells, sfRNA inhibited the phosphorylation and
nuclear localisation of IRF‐3; although, the mode of action is still to
be determined. Furthermore, sfRNA‐deficient WNV and YFV, which
replicate poorly in interferon competent cells, are able to replicate suc-
cessfully in cells deficient in major factors involved in the IFN response
(Funk et al., 2010; Schuessler et al., 2012; Silva, Pereira, Dalebout,
Spaan, & Bredenbeek, 2010). sfRNA‐deficient WNV was also found
to be more sensitive to IFN pretreatment; however, replication was
rescued in the presence of INFAR neutralising antibodies. Therefore,sfRNA must interact with the IFN‐I response in infected cells
(Schuessler et al., 2012).
During DENV infection, it has been shown that sfRNA antagonises
a group of proteins, G3BP1, G3BP2, and CAPRIN1, which have
previously been implicated in modulating viral infection through the
regulation of several ISGs and ISG mRNA translation (Bidet, Dadlani,
& Garcia‐Blanco, 2014; Cobos Jimenez et al., 2015; Humoud et al.,
2016; Katsafanas & Moss, 2004). It was also found that DENV‐2
sfRNA colocalises and interacts with G3BP1, G3BP2, and CAPRIN1.
A chimeric YFV‐DENV sfRNA that lacked stem loop II (SL‐II) but
contained the equivalent YFV structures was shown to have lower
binding affinity to G3BP1, and when compared withWT DENV sfRNA,
was unable to reduce the transcription of host ISGs. It was suggested
that DENV sfRNA sequesters G3BP1, G3BP2, and CAPRIN1, thereby
preventing the upregulation of ISG expression. Interestingly, this
interaction was not found in experiments using DENV‐3, KUNV, or
YFV‐17D 3'UTRs, highlighting that the mechanisms through which
sfRNA antagonises the IFN response are highly divergent between
other flaviviruses (Bidet et al., 2014). Indeed, ZIKV sfRNA has recently
been shown to function as both a RIG‐I and MDA5 agonist and
demonstrates broader antagonistic activity compared to DENV‐2,
which affects RIG‐I only (Donald et al., 2016).
Structural analysis and RNA‐fold predictions have been used to
determine the structure of sfRNAs. Studies mapping the extensive
secondary structures of MVEV and DENV sfRNAs revealed particular
three‐way helix junction conformations that are required for XRN1
stalling and preservation of the integrity of the RNA (Chapman,
Costantino et al., 2014; Chapman, Moon et al., 2014). The crystal
structure ofMVEV indicates a ring‐like structure in SL‐II, throughwhich
the 5′ end of the XRN1‐resistant RNA protrudes.When XRN1 encoun-
ters this structure, it attempts to pull the 5′ end of the sfRNA through
this ring, causing the structure to tighten and the enzyme to stall
(Chapman et al., 2014). In the case of ZIKV sfRNA, it has been
determined that two XRN1‐resistant RNAs (xrRNAs) are produced
during infection. Referred to as xrRNA1 and xrRNA2, these are
produced as a result of XRN1 stalling at SL‐I and SL‐II, respectively
(Figure 1b). This differential sfRNA production may be the result of
cellular mechanisms; however, the significance of this is unclear
(Akiyama et al., 2016). Such data will be very useful for analysing the
mechanism of this IFN antagonist further (Akiyama et al., 2016; Donald
et al., 2016).
TRIM25, a modulator of the IFN‐I response, has also been
identified as a target of DENV sfRNA (Manokaran et al., 2015).
TRIM25 functions as an E3 ligase, which adds poly‐ubiquitin chains
to the amino‐terminal CARDs of RIG‐I (Gack, 2014). This is thought
to facilitate the interaction of RIG‐I with MAVS, thus modulating
downstream signalling of the IFN‐I response. TRIM25 and MAVS were
also shown to interact with DENV sfRNA; however, although TRIM25
was found to be enriched for bound sfRNA, MAVS was not
(Manokaran et al., 2015).2 | CONCLUDING REMARKS
The vertebrate IFN response is vital to restrain a number of pathogenic
infections, including flavivirus infections. Investigations into
6 of 8 CUMBERWORTH ET AL.flavivirus–host cell interactions have identified a number of important
molecular components involved in counteracting this response and
contributing to viral pathogenesis and disease development. The
evolution of specific IFN‐I response antagonists to subvert the host
immune response at definitive stages of the cascade have long
reaching effects in terms of viral growth kinetics and fitness, many of
which are still to be fully investigated. In particular, enhancing our
understanding of sfRNA interactions with cellular immune responses
represents an exciting new field of study that may greatly impact our
understanding of medically important flavivirus infections. Research
has shown that different flaviviruses use different approaches to
counteract host innate immune responses, and a better understanding
of these interactions is important for the development of effective
prophylaxis and anti‐viral therapeutics that will both inhibit the spread
of these emerging infections and improve medical outcomes.
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